OpenBilldrug price receipt

NADAC week of 2026-10-14

CEFIXIME 400 MG CAPSULE

For 30 capsules

Pharmacies pay

$300.85 filed

30 × $10.02817 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$350.98 estimated

$300.85 + $45.13 (15%) + $5.00 fee per fill = $350.98

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CEFIXIME 400 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cefixime.

FDA gives its dosage form as capsule and its route as oral.

Its labelers, the companies named on the label, are Aurobindo Pharma Limited, Ascend Laboratories, LLC and Lupin Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Cephalosporin Antibacterial.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $300.85 for 30 capsules (30 × $10.02817 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 5 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name cefixime with CEFIXIME 400 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
CEFIXIME 100 MG/5 ML SUSP
generic · powder, for suspension
$2.44303 per ML filed
eff. 2026-09-23
We don’t know yet
CEFIXIME 200 MG/5 ML SUSP
generic · powder, for suspension
$3.42661 per ML filed
eff. 2026-09-23
We don’t know yet
CEFIXIME 400 MG CAPSULE this page
generic · capsule
$10.02817 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $10.02817 per EA filed.

Of the 20 other products in FDA’s Cephalosporin Antibacterial class priced per EA, 0 have a higher middle NADAC price and 20 a lower one. The one in the middle is CEFPODOXIME 100 MG TABLET, at $1.0434 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.